Mepolizumab improves small airway function in severe eosinophilic asthma
L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia). Mepolizumab improves small airway function in severe eosinophilic asthma. 2434
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: